© 2004 by Oxford University Press
© 2004 Oxford University Press
ARTICLE |
Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human Papillomavirus
Affiliations of authors: Departments of Otolaryngology—Head and Neck Surgery (BJMB, WJHK, HJRS, CRL, RHB) and Pathology (PJFS, CJLMM), VU University Medical Center, Amsterdam, The Netherlands.
Correspondence to: Boudewijn J. M. Braakhuis, PhD, Department of Otolaryngology—Head and Neck Surgery, Room 1D116, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands (e-mail: bjm.braakhuis{at}vumc.nl)
Background: Transcriptionally active high-risk human papilloma viruses (HPVs), particularly HPV type 16 (HPV16), are found in a subset of head and neck squamous-cell carcinomas (HNSCCs). HPV16-associated carcinogenesis is mediated by expression of the viral E6 and E7 oncoproteins, which cause deregulation of the cell cycle by inactivating p53 and pRb, respectively. We tested the hypothesis that HPV-associated HNSCCs display a pattern of genetic alterations different from those of HNSCCs without HPV DNA. Methods: Polymerase chain reaction–based assays were used to examine 143 consecutive HNSCCs (106 of the oral cavity and 37 of the oropharynx) for the presence of HPV DNA and for viral E6 and/or E7 messenger RNA (mRNA) expression. The HPV DNA–and E6 and E7 mRNA–positive HNSCCs and an equal number of HPV DNA–negative HNSCCs were further analyzed for mutations in TP53, the gene encoding p53, and for allelic loss of 28 microsatellite markers at chromosome arms 3p, 6q, 8p, 9p, 13q, 17p, and 18q, including markers located in regions of chromosome arms 9p and 17p that harbor genes involved the p53 and pRb pathways. All statistical tests were two-sided. Results: Twenty-four (16.7%) of the 143 HNSCCs were positive for HPV16 DNA, and 12 of these HNSCCs (8.4% of total number) expressed E6 and E7 mRNAs. None of the HPV DNA–and E6/E7 mRNA–positive tumors had TP53 gene mutations, whereas nine (75%) of the 12 HPV DNA–negative tumors had such mutations (P<.001). Compared with the HPV DNA–negative HNSCCs, the E6/E7 mRNA–positive HNSCCs had statistically significantly lower levels of allelic loss for 13 of the 15 markers on 3p, 9p, and 17p. Conclusions: HNSCCs with transcriptionally active HPV16 DNA are characterized by occasional chromosomal loss, whereas HNSCCs lacking HPV DNA are characterized by gross deletions that involve whole or large parts of chromosomal arms and that already occur early in HNSCC development. These distinct patterns of genetic alterations suggest that HPV16 infection is an early event in HNSCC development.
CiteULike 
Connotea 
Del.icio.us What's this?
Editorial about this Article
- How Does Human Papillomavirus Contribute to Head and Neck Cancer Development?
- Li Mao and Waun Ki Hong
J Natl Cancer Inst 2004 96: 978-980.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
|
|
 |
|
  M. L. Gillison, G. D'Souza, W. Westra, E. Sugar, W. Xiao, S. Begum, and R. Viscidi Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers J Natl Cancer Inst, March 19, 2008; 100(6): 407 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Harris IV, M. E. Anderson, and J. H. Lee The Effect of Proteasome Inhibition on p53 Degradation and Proliferation in Tonsil Epithelial Cells Arch Otolaryngol Head Neck Surg, February 1, 2008; 134(2): 157 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Westra, J. M. Taube, M.L. Poeta, S. Begum, D. Sidransky, and W. M. Koch Inverse Relationship between Human Papillomavirus-16 Infection and Disruptive p53 Gene Mutations in Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., January 15, 2008; 14(2): 366 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Applebaum, C. S. Furniss, A. Zeka, M. R. Posner, J. F. Smith, J. Bryan, E. A. Eisen, E. S. Peters, M. D. McClean, and K. T. Kelsey Lack of Association of Alcohol and Tobacco with HPV16-Associated Head and Neck Cancer J Natl Cancer Inst, December 5, 2007; 99(23): 1801 - 1810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Friedman, L. Nottingham, P. Duggal, F. G. Pernas, B. Yan, X. P. Yang, Z. Chen, and C. Van Waes Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer Clin. Cancer Res., November 15, 2007; 13(22): 6568 - 6578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Lee, X. P. Yang, B. Yan, J. Friedman, P. Duggal, L. Bagain, G. Dong, N. T. Yeh, J. Wang, J. Zhou, et al. A Novel Nuclear Factor-{kappa}B Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status Clin. Cancer Res., October 1, 2007; 13(19): 5680 - 5691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. C. Ukpo, E. J. Moore, D. I. Smith, H. Williams, C. D. Higgins, D. H. Crawford, B. J. Braakhuis, P. J. Snijders, C. R. Leemans, and M. L. Gillison Human Papillomavirus and Oropharyngeal Cancer N. Engl. J. Med., September 13, 2007; 357(11): 1156 - 1158. [Full Text] [PDF]
|
|
|
|
 |
|
 S Mitra, S Banerjee, C Misra, R K Singh, A Roy, A Sengupta, C K Panda, and S Roychoudhury Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population J. Clin. Pathol., September 1, 2007; 60(9): 1040 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.C.R. Ragin, F. Modugno, and S.M. Gollin The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus J. Dent. Res., February 1, 2007; 86(2): 104 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Licitra, F. Perrone, P. Bossi, S. Suardi, L. Mariani, R. Artusi, M. Oggionni, C. Rossini, G. Cantu, M. Squadrelli, et al. High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma J. Clin. Oncol., December 20, 2006; 24(36): 5630 - 5636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Perrone, S. Suardi, E. Pastore, P. Casieri, M. Orsenigo, S. Caramuta, G. Dagrada, M. Losa, L. Licitra, P. Bossi, et al. Molecular and Cytogenetic Subgroups of Oropharyngeal Squamous Cell Carcinoma. Clin. Cancer Res., November 15, 2006; 12(22): 6643 - 6651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Strati, H. C. Pitot, and P. F. Lambert Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model PNAS, September 19, 2006; 103(38): 14152 - 14157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fakhry and M. L. Gillison Clinical Implications of Human Papillomavirus in Head and Neck Cancers J. Clin. Oncol., June 10, 2006; 24(17): 2606 - 2611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Reddy, S. Ganesh, and D.-C. Yu Enhanced gene transfer and oncolysis of head and neck cancer and melanoma cells by fiber chimeric oncolytic adenoviruses. Clin. Cancer Res., May 1, 2006; 12(9): 2869 - 2878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Weinberger, Z. Yu, B. G. Haffty, D. Kowalski, M. Harigopal, J. Brandsma, C. Sasaki, J. Joe, R. L. Camp, D. L. Rimm, et al. Molecular Classification Identifies a Subset of Human Papillomavirus-Associated Oropharyngeal Cancers With Favorable Prognosis J. Clin. Oncol., February 10, 2006; 24(5): 736 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J.C. Slebos, Y. Yi, K. Ely, J. Carter, A. Evjen, X. Zhang, Y. Shyr, B. M. Murphy, A. J. Cmelak, B. B. Burkey, et al. Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., February 1, 2006; 12(3): 701 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T. Smith, M. Lin, R. M. Brena, J. C. Lang, D. E. Schuller, G. A. Otterson, C. D. Morrison, D. J. Smiraglia, and C. Plass Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer PNAS, January 24, 2006; 103(4): 982 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J.T. van Zeeburg, P. J.F. Snijders, G. Pals, M. A.J.A. Hermsen, M. A. Rooimans, G. Bagby, J. Soulier, E. Gluckman, J. Wennerberg, C. R. Leemans, et al. Generation and Molecular Characterization of Head and Neck Squamous Cell Lines of Fanconi Anemia Patients Cancer Res., February 15, 2005; 65(4): 1271 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Kreimer, G. M. Clifford, P. Boyle, and S. Franceschi Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 467 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mao and W. K. Hong How Does Human Papillomavirus Contribute to Head and Neck Cancer Development? J Natl Cancer Inst, July 7, 2004; 96(13): 978 - 980. [Full Text] [PDF]
|
|